DiaSorin SpA
James Prendergast has a diverse work experience in the pharmaceutical industry. James is currently working as the Director of Clinical and Scientific Education at DiaSorin since 2022. Prior to this, they held various roles at Roche, including Market Access Director and National Director Clinician Sales Team from 2015 to 2022. James also worked at Roche Diagnostics as a Director and held the role of Strategic Business Development Manager from 2009 to 2010. James began their career at Pfizer Pharmaceuticals, where they served as a Senior Master Level District Manager from 1996 to 2009.
James Prendergast attended The Ohio State University from 1981 to 1987, earning a Bachelor of Science degree in Pharmacy.
This person is not in any offices
DiaSorin SpA
4 followers
DiaSorin SpA is an Italy-based company engaged in healthcare industry. The Company specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The Company develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company's business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. It operates through ELISA immunodiagnostic business portfolio.